Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
When Hardcore Pharma Investors Meet Enthusiastic Oncologists
This article is for subscribers only. Welcome back to Bloomberg's Health Monitor, a weekly look at the boardroom decisions, scientific advances and policy fights shaping the future of medicine. Sign up now if you're not already on the list. The…
BridgeBio Pharma: Q3 Earnings Snapshot
PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — BridgeBio Pharma Inc. (BBIO) on Thursday reported a loss of $56.7 million in its third quarter. The Palo Alto, California-based company said it had a loss of 42 cents per share. The…
Pharma companies continue to pay millions to doctors
In 2025, these payments – in the form of conference attendance fees, accommodation expenses, fees and consultancy fees – totalled CHF234 million ($283 million). This figure is CHF28 million lower than in 2024, but the decline is…
West Pharma earnings show it's more than a GLP-1 play. Why we see more upside
West Pharmaceutical Services once again showed that it's more than just a GLP-1 play. Since CNBC highlighted the stock's attractive valuation in August, shares have gained around 20%. On Thursday, the stock hit a 52-week high in the wake of a…
Should You Buy Royalty Pharma Stock Before Nov. 4?
Royalty Pharma (RPRX +1.64%) will report Q3 2026 earnings pre-market on Nov. 4. After pulling back in September due to a major setback with one of its drug candidates, the pharmaceutical royalty holding company's shares have been soaring back…
Embattled Purdue Pharma exec ordered to stop blocking sale of mansion to fund opioid settlements
Former Purdue Pharma chairman Richard Sackler was ordered stop interfering with the sale of his sprawling Connecticut mansion — as the Sackler family's $7.4 billion opioid settlement threatens to cost him one of his luxury homes. A federal…
Economic Times Reports Piramal Pharma Led Four-Stock RSI Screen
The Economic Times reported that Piramal Pharma Limited led a four-stock Indian momentum screen on Oct. 28, when each selected share rose more than 6%. The outlet put Piramal Pharma's Relative Strength Index (RSI) at 71.93, compared with 49.11…
Pharma H1 exports up 5% to $16.14-bn. as Europe offsets U.S. slowdown
India's pharmaceutical exports rose 4.90% year-on-year (YoY) to $16.14 billion in the first half of FY27, as strong demand from Europe, Latin America and ASEAN markets offset a decline in shipments to North America, including the crucial U.S.
Belgium's deputy PM wants to use 'trade bazooka' on US over pharma threats
The Trump administration has been pressuring European governments to pay more for medicines under its “most-favored-nation” policy as it seeks to bring American drug prices into line with those in other wealthy countries. Washington…
Swiss stock market climbs to new all-time high
On Thursday, the blue-chip stocks provided support for the SMI. Shares in the pharmaceutical group Novartis rose by 2% at around 9:50 am, those of the food giant Nestlé by 1% and those of the pharmaceutical company Roche by 0.5%. By…
aTyr Pharma (NASDAQ:ATYR) Sees Large Volume Increase - Here's Why
Shares of aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) saw an uptick in trading volume on Thursday. Approximately 111,433 shares were traded during mid-day trading, an increase of 78% from the average daily volume of 62,656 shares. The stock…
BridgeBio Pharma (NASDAQ:BBIO) Posts Earnings Results
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) announced its earnings results on Thursday. The company reported ($0.42) EPS for the quarter, topping the consensus estimate of ($0.54) by $0.12, FiscalAI reports. The firm had revenue of $353.17…
Swiss railways plans CHF7 billion digital upgrade
The mid-terms and democracy, a new national park, and political hamburgers Read more: The mid-terms and democracy, a new national park, and political hamburgers Switzerland, China and Germany's mistakes Read more: Switzerland, China and Germany's…
Urogen Pharma (URGN) Projected to Announce Quarterly Earnings on Wednesday
Urogen Pharma (NASDAQ:URGN - Get Free Report) will likely be releasing its Q3 2026 results before the market opens on Wednesday, November 4th. Analysts expect Urogen Pharma to announce earnings of $0.10 per share and revenue of $90.58 million for…
Democrats have big healthcare plans. The industry is preparing for a fight.
Americans want changes to their healthcare, and the candidates in this year's midterms are making bold promises about how they are going to improve it: Medicare-for-all, or a public health insurance option, or free primary care for everyone. If…
Receive a Daily briefing on Pharma Industry News
Get Started